Global Brain Monitoring Devices Market - Industry Trends and Forecast to 2024

  • Monitoring Devices
  • Upcoming Reports
  • Mar 2017
  • Global
  • 350 Pages
  • No of Tables: 50
  • No of Figures: 250

Global Brain Monitoring Market, By Product (Devices {EEG, MEG, ICP}, Accessories), Application (TBI, Stroke, Headache, Dementia, Epilepsy, Parkinson), End-User (Hospitals, Neurological Centers & Diagnostic Centers), Geography (North America, Europe, APAC, South America, MEA) – Industry Trends & Forecast to 2024

Market Analysis: Global Brain Monitoring Devices Market

Global Brain Monitoring Market is expected to reach USD 2.0 billion by 2024 from USD 1.2 billion in 2016, at a CAGR of 7.1% in the forecast period 2017 to 2024. The new market report contains data for historic years 2014 & 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.

Brain Monitoring Devices Market

Market Definition: Global Brain Monitoring Devices Market

Brain monitoring is the process of tracking the activity of various parameters associated with the functionality of the brain. These include electrical activity, blood flow & magnetic activity, pressure surrounding the brain, cerebral oxygen, saturation & anomalies such as tumors or infections. The various tools available for brain monitoring include electroencephalography (EEG), magnetoencephalography (MEG) & intracranial pressure monitors.

The increasing global incidence and prevalence of neurological disorders, growing awareness about neurodegenerative diseases, technological advancements in brain monitoring devices, and growing incidence of traumatic brain injuries are major factors driving the market growth for brain monitoring. On the other hand, shortage of trained professionals to operate brain monitoring devices, high cost associated with complex brain monitoring devices, and concerns regarding the accuracy of diagnostic devices are some of the factors that may hinder the growth this market.

Market Segmentation: Global Brain Monitoring Devices Market

  • Global brain monitoring market is segmented on the basis of product, application, end-user and by geography.
  • Based on product type, the brain monitoring devices market is categorized into devices and accessories. Factors such as increasing incidence of neurological, neurodegenerative, psychotic, and sleep disorders; the need for early diagnosis; availability of innovative portable and wearable home-based monitoring devices; and increasing patient awareness are driving the growth for the brain monitoring market.
  • Based on procedure, the brain monitoring devices market is segmented into invasive and non-invasive procedures. The risk of complications such as hemorrhage and infections is lower in non-invasive procedures, resulting in their higher uptake. Moreover, there is greater focus on research for the development of advanced non-invasive devices for brain monitoring. These are some of the major factors driving the market growth for non-invasive brain monitoring in the forecast period.
  • Based on the geographical regions the market is segmented  into 5 geographical regions, North America, Europe, Asia-Pacific, South America, and the Rest of the World (RoW). North America is estimated to account for the largest share of the market in 2015. The market in Asia is poised to witness the highest growth, attributed to factors such as increasing aging population, availability of low-cost labor and skilled manpower, increase in disposable incomes, rising prevalence of neurodegenerative disorders, and increasing government emphasis on healthcare reforms in the region.

Competitive Analysis: Global Brain Monitoring Devices Market

The global brain monitoring market report contains an in-depth profiling of the key market players, along with the recent developments (New product launches, partnerships, agreements, collaborations, and joint ventures) and strategies adopted by them to sustain and strengthen their positions in the market. For example, in March 2017, Medtronic plc received FDA 510(k) clearance for Reveal LINQ(TM) Insertable Cardiac Monitor (ICM) with TruRhythm(TM) Detection which is an advanced cardiac monitor offering improved accuracy to better identify abnormal heartbeats.

Major Market Competitors: Global Brain Monitoring Devices Market

Some of the major players operating in Global Brain Monitoring Devices Market are Nihon Kohden Corporation, Philips Healthcare, Metronic PLC, GE Healthcare, Siemens Healthcare, Natus Medical Incorporated, Compumedics Limited, Electrical Geodesics, Inc. CAS Medical Systems Inc, Advanced Brain Monitoring, B. Braun Medical, Becton, Dickinson & Company, DePuySynthes Companies, Cadwell Industries, Inc, Masimo Corporation, Elekta AB (pub), Integra LifeSciences Corporation, Rimed Inc., Yokogawa Electric Corporation, EMOTIV Inc., and Neural Analytics, among others.


SKU-
1.INTRODUCTION

1.1.OVERVIEW OF THE GLOBAL BRAIN MONITORING MARKET

1.2.CURRENCY AND PRICING

1.3.LIMITATION

1.4.MARKETS COVERED

2      MARKET SEGMENTATION

2.1.KEY TAKEAWAYS

2.2.ARRIVING AT THE GLOBAL BRAIN MONITORING MARKET SIZE

2.2.1.MARKET CRACKDOWN APPROACH 2.2.2.COMPANY REVENUE AND MARKET SHARE ANALYSIS 2.2.3.DATA TRIANGULATION 2.2.4.KEY DATA POINTS FROM PRIMARY SOURCES 2.2.5.KEY DATA POINTS FROM SECONDARY SOURCES 2.2.6.PORTER’S FIVE FORCES MATRIX 2.2.7.PEST ANALYSIS 2.2.8.EPIDEMIOLOGY FORECASTING MODELS

2.3.GLOBAL BRAIN MONITORING MARKET: RESEARCH SNAPSHOT

2.4.ASSUMPTIONS

3.MARKET OVERVIEW

3.1.DRIVERS

3.2.RESTRAINTS

3.3.OPPORTUNITIES

3.4.CHALLENGES

4      EXECUTIVE SUMMARY 5      PREMIUM INSIGHTS 6      GLOBAL BRAIN MONITORING MARKET, BY PRODUCT TYPE

6.1.OVERVIEW

6.2.DEVICES, BY PRODUCT TYPE

6.2.1.EEG 6.2.2.MEG 6.2.3.ICP

6.3.ACCESSORIES, BY PRODUCT TYPE

6      GLOBAL BRAIN MONITORING MARKET, BY PROCEDURES

6.1.OVERVIEW

6.2.INVASIVE PROCEDURES

6.3.NON-INVASIVE PROCEDURES

7      GLOBAL BRAIN MONITORING MARKET, BY APPLICATION

7.1.OVERVIEW

7.2.TBI

7.3.STROKE

7.4.HEADACHE

7.5.DEMENTIA

7.6.EPILEPSY

7.7.PARKINSON

8      GLOBAL BRAIN MONITORING MARKET, BY END USER

8.1.OVERVIEW

8.2.HOSPITALS

8.3.NEUROLOGICAL CENTERS

8.4.DIAGNOSTIC CENTERS

9      GLOBAL BRAIN MONITORING MARKET, BY GEOGRAPHY

9.1.COUNTRYWISE GLOBAL BRAIN MONITORING MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)

9.1.1.NORTH AMERICA 9.1.1.1.U.S. 9.1.1.2.CANADA 9.1.1.3.MEXICO 9.1.2.EUROPE 9.1.2.1.GERMANY 9.1.2.2.FRANCE 9.1.2.3.U.K. 9.1.2.4.ITALY 9.1.2.5.SPAIN 9.1.2.6.RUSSIA 9.1.2.7.TURKEY 9.1.2.8.BELGIUM 9.1.2.9.NETHERLANDS 9.1.2.10.SWITZERLAND 9.1.2.11.REST OF EUROPE 9.1.3.ASIA-PACIFIC (APAC) 9.1.3.1.JAPAN 9.1.3.2.CHINA 9.1.3.3.SOUTH KOREA 9.1.3.4.INDIA 9.1.3.5.AUSTRALIA 9.1.3.6.SINGAPORE 9.1.3.7.THAILAND 9.1.3.8.MALAYSIA 9.1.3.9.INDONESIA 9.1.3.10.PHILIPPINES 9.1.3.11.REST OF APAC 9.1.4.LATIN AMERICA 9.1.4.1.BRAZIL 9.1.4.2.REST OF LATIN AMERICA 9.1.5.MIDDLE EAST AND AFRICA 9.1.5.1.SOUTH AFRICA 9.1.5.2.REST OF MIDDLE EAST AND AFRICA

9.2.KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES

10.GLOBAL BRAIN MONITORING MARKET: COMPETITIVE LANDSCAPE

10.1.GLOBAL BRAIN MONITORING MARKET: COMPANY SHARE ANALYSIS

10.2.NORTH AMERICA BRAIN MONITORING MARKET: COMPANY SHARE ANALYSIS

10.3.EUROPE BRAIN MONITORING MARKET: COMPANY SHARE ANALYSIS

10.4.APAC BRAIN MONITORING MARKET: COMPANY SHARE ANALYSIS

10.5.MEA BRAIN MONITORING MARKET: COMPANY SHARE ANALYSIS

10.6.SOUTH AMERICA BRAIN MONITORING MARKET: COMPANY SHARE ANALYSIS

10.7.MERGERS & ACQUISITIONS

10.8.NEW PRODUCT DEVELOPMENT & APPROVALS

10.9.EXPANSIONS

10.10.REGULATORY CHANGES

10.11.PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS

11.GLOBAL BRAIN MONITORING MARKET, COMPANY PROFILES

11.1.NIHON KOHDEN CORPORATION

11.1.1.COMPANY OVERVIEW

11.1.2.FINANCIAL ANALYSIS

11.1.3.PRODUCT MATRIX

11.1.4.RECENT DEVELOPMENTS

11.1.5.DATABRIDGE ANALYSIS

11.2.PHILIPS HEALTHCARE

11.2.1.COMPANY OVERVIEW

11.2.2.FINANCIAL ANALYSIS

11.2.3.PRODUCT MATRIX

11.2.4.RECENT DEVELOPMENTS

11.2.5.DATABRIDGE ANALYSIS

11.3.METRONIC PLC

11.3.1.COMPANY OVERVIEW

11.3.2.FINANCIAL ANALYSIS

11.3.3.PRODUCT MATRIX

11.3.4.RECENT DEVELOPMENTS

11.3.5.DATABRIDGE ANALYSIS

11.4.GE HEALTHCARE

11.4.1.COMPANY OVERVIEW

11.4.2.FINANCIAL ANALYSIS

11.4.4.PRODUCT MATRIX

11.4.4.RECENT DEVELOPMENTS

11.4.5.DATABRIDGE ANALYSIS

11.5.SIEMENS HEALTHCARE

11.5.1.COMPANY OVERVIEW

11.5.2.FINANCIAL ANALYSIS

11.5.3.PRODUCT MATRIX

11.5.4.RECENT DEVELOPMENTS

11.5.5.DATABRIDGE ANALYSIS

11.6   NATUS MEDICAL INCORPORATED

11.6.1.COMPANY OVERVIEW

11.6.2.FINANCIAL ANALYSIS

11.6.3.PRODUCT MATRIX

11.6.4.RECENT DEVELOPMENTS

11.6.5.DATABRIDGE ANALYSIS

11.7.COMPUMEDICS LIMITED

11.7.1.COMPANY OVERVIEW

11.7.2.FINANCIAL ANALYSIS

11.7.3.PRODUCT MATRIX

11.7.4.RECENT DEVELOPMENTS

11.7.5.DATABRIDGE ANALYSIS

11.8.ELECTRICAL GEODESICS, INC.

11.8.1.COMPANY OVERVIEW

11.8.2.FINANCIAL ANALYSIS

11.8.3.PRODUCT MATRIX

11.8.4.RECENT DEVELOPMENTS

11.8.5.DATABRIDGE ANALYSIS

11.9.CAS MEDICAL SYSTEMS INC.

11.9.1.COMPANY OVERVIEW

11.9.2.FINANCIAL ANALYSIS

11.9.3.PRODUCT MATRIX

11.9.4.RECENT DEVELOPMENTS

11.9.5.DATABRIDGE ANALYSIS

11.10.BECTON, DICKINSON & COMPANY

11.10.1.COMPANY OVERVIEW

11.10.2.FINANCIAL ANALYSIS

11.10.3.PRODUCT MATRIX

11.10.4.RECENT DEVELOPMENTS

11.10.5.DATABRIDGE ANALYSIS

11.11.DEPUYSYNTHES COMPANIES

11.11.1.COMPANY OVERVIEW

11.11.2.FINANCIAL ANALYSIS

11.11.3.PRODUCT MATRIX

11.11.4.RECENT DEVELOPMENTS

11.11.5.DATABRIDGE ANALYSIS

11.12.CADWELL INDUSTRIES, INC.

11.12.1.COMPANY OVERVIEW

11.12.2.FINANCIAL ANALYSIS

11.12.3.PRODUCT MATRIX

11.12.4.RECENT DEVELOPMENTS

11.12.5.DATABRIDGE ANALYSIS

11.13.INTEGRA LIFESCIENCES CORPORATION

11.13.1.COMPANY OVERVIEW

11.13.2.FINANCIAL ANALYSIS

11.13.3.PRODUCT MATRIX

11.13.4.RECENT DEVELOPMENTS

11.13.5.DATABRIDGE ANALYSIS

11.14.YOKOGAWA ELECTRIC CORPORATION

11.14.1.COMPANY OVERVIEW

11.14.2.FINANCIAL ANALYSIS

11.14.3.PRODUCT MATRIX

11.14.4.RECENT DEVELOPMENTS

11.14.5.DATABRIDGE ANALYSIS

11.15 EMOTIV INC.

11.15.1.COMPANY OVERVIEW

11.15.2.FINANCIAL ANALYSIS

11.15.3.PRODUCT MATRIX

11.15.4..RECENT DEVELOPMENTS

11.15.5.DATABRIDGE ANALYSIS

11.16.NEURAL ANALYTICS

11.16.1.COMPANY OVERVIEW

11.16.2.FINANCIAL ANALYSIS

11.16.3.PRODUCT MATRIX

11.16.4.RECENT DEVELOPMENTS

11.16.5.DATABRIDGE ANALYSIS

11.17.RIMED INC.

11.17.1.COMPANY OVERVIEW

11.17.2.FINANCIAL ANALYSIS

11.17.3.PRODUCT MATRIX

11.17.4.RECENT DEVELOPMENTS

11.17.5.DATABRIDGE ANALYSIS

11.18.ADVANCED BRAIN MONITORING

11.18.1.COMPANY OVERVIEW

11.18.2.FINANCIAL ANALYSIS

11.18.3.PRODUCT MATRIX

11.18.4.RECENT DEVELOPMENTS

11.18.5DATABRIDGE ANALYSIS

11.19.B. BRAUN MEDICAL

11.19.1.COMPANY OVERVIEW

11.19.2.FINANCIAL ANALYSIS

11.19.3.PRODUCT MATRIX

11.19.4.RECENT DEVELOPMENTS

11.19.5.DATABRIDGE ANALYSIS

11.20.MASIMO CORPORATION

11.20.1.COMPANY OVERVIEW

11.20.2.FINANCIAL ANALYSIS

11.20.3.PRODUCT MATRIX

11.20.4.RECENT DEVELOPMENTS

11.20.5.DATABRIDGE ANALYSIS

11.21.ELEKTA AB (PUB)

11.21.1.COMPANY OVERVIEW

11.21.2.FINANCIAL ANALYSIS

11.21.3.PRODUCT MATRIX

11.21.4.RECENT DEVELOPMENTS

11.21.5.DATABRIDGE ANALYSIS

12.APPENDIX 13.ABOUT DATA BRIDGE MARKET RESEARCH

Please fill in the below form for detailed List of Table

Please fill in the below form for detailed List of Figure

Please fill in the below form for detailed Inquire Before Buying

Choose License Type
  • $5400.00
  • $4200.00
BUY NOW ADD TO CART